EPIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $12,086,998.93

ESSA Pharma Insider Trading History Chart

ESSA Pharma Share Price & Price History

^$1.63

▼ -0.03 (-1.81%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

ESSA Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	Growth N. V. Biotech	major shareholder	Sell	7,879,583	$1.53	$12,055,761.99
10/7/2024	Peter Virsik	COO	Sell	694	$6.03	$4,184.82	7,776
9/9/2024	Peter Virsik	COO	Sell	694	$6.00	$4,164.00	8,470
9/3/2024	Peter Virsik	COO	Sell	2,082	$6.03	$12,554.46	9,164
5/6/2024	Peter Virsik	COO	Sell	694	$6.95	$4,823.30	11,246
4/5/2024	Peter Virsik	COO	Sell	694	$7.94	$5,510.36	11,940
3/5/2024	Peter Virsik	COO	Sell	694	$8.98	$6,232.12	12,634
1/16/2024	Peter Virsik	COO	Sell	1,718	$10.01	$17,197.18	14,022
1/5/2024	Peter Virsik	COO	Sell	699	$6.11	$4,270.89	14,022
12/14/2023	David Ross Parkinson	CEO	Buy	9,223	$2.30	$21,212.90	65,675
11/21/2023	Franklin M Berger	Director	Buy	23,259	$5.73	$133,274.07	784,404
11/2/2023	Franklin M Berger	Director	Buy	60,000	$5.35	$321,000.00	744,404
10/26/2022	Growth N V Biotech	Major Shareholder	Buy	1,500,000	$3.98	$5,970,000.00	7,379,583
7/18/2022	Growth N V Biotech	Major Shareholder	Buy	300,000	$3.16	$948,000.00	5,879,583
7/14/2022	Growth N V Biotech	Major Shareholder	Buy	347,204	$2.79	$968,699.16	5,337,918
6/30/2022	David Ross Parkinson	CEO	Buy	4,887	$2.96	$14,465.52	32,108
4/27/2022	Growth N V Biotech	Major Shareholder	Sell	25,100	$5.85	$146,835.00	4,990,714

See Full Table

SEC Filings (Institutional Ownership Changes) for ESSA Pharma (NASDAQ:EPIX)

75.12% of ESSA Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ESSA Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/18/2025	GTS Securities LLC	16,700	$30K	0.0%	N/A	0.038%
2/17/2025	Soleus Capital Management L.P.	2,262,026	$4.05M	0.3%	-47.2%	5.096%
2/17/2025	Squarepoint Ops LLC	14,525	$26K	0.0%	N/A	0.033%
2/17/2025	Two Sigma Advisers LP	82,600	$0.15M	0.0%	N/A	0.186%
2/17/2025	Two Sigma Investments LP	211,204	$0.38M	0.0%	N/A	0.476%
2/17/2025	Tang Capital Management LLC	4,300,000	$7.70M	0.5%	N/A	9.687%
2/17/2025	RTW Investments LP	1,113,002	$1.99M	0.0%	-65.9%	2.507%
2/17/2025	Cubist Systematic Strategies LLC	26,287	$47K	0.0%	N/A	0.059%
2/17/2025	Bank of America Corp DE	812,310	$1.45M	0.0%	+10,153,775.0%	1.830%
2/17/2025	BNP Paribas Financial Markets	164,595	$0.30M	0.0%	+269.9%	0.371%
2/14/2025	Jane Street Group LLC	45,810	$82K	0.0%	N/A	0.103%
2/14/2025	Schonfeld Strategic Advisors LLC	48,843	$87K	0.0%	-82.4%	0.110%
2/14/2025	Vazirani Asset Management LLC	50,000	$90K	0.3%	N/A	0.113%
2/14/2025	Two Sigma Securities LLC	15,943	$29K	0.0%	N/A	0.036%
2/14/2025	Altium Capital Management LLC	1,428,000	$2.56M	0.7%	N/A	3.217%
2/13/2025	Marshall Wace LLP	181,217	$0.32M	0.0%	N/A	0.408%
2/13/2025	XTX Topco Ltd	37,526	$67K	0.0%	N/A	0.085%
2/12/2025	Aldebaran Capital LLC	397,523	$0.71M	0.7%	N/A	0.896%
2/7/2025	Lepercq Multi Asset Fund	30,200	$54K	0.0%	N/A	0.068%
2/7/2025	BML Capital Management LLC	4,221,546	$7.56M	4.7%	N/A	9.510%
1/17/2025	Magnus Financial Group LLC	55,206	$99K	0.0%	N/A	0.124%
1/13/2025	FNY Investment Advisers LLC	25,000	$44K	0.0%	N/A	0.056%
11/15/2024	RTW Investments LP	3,261,496	$19.77M	0.3%	+41.9%	7.351%
11/15/2024	Parkman Healthcare Partners LLC	345,902	$2.10M	0.3%	+37.2%	0.780%
11/14/2024	Bellevue Group AG	7,879,583	$47.75M	0.8%	-0.1%	17.759%
11/14/2024	PFM Health Sciences LP	2,742,936	$16.62M	0.9%	-7.5%	6.182%
5/16/2024	Janus Henderson Group PLC	1,175,242	$9.98M	0.0%	+7.9%	2.657%
5/15/2024	Bellevue Group AG	7,889,583	$66.98M	1.0%	-0.1%	17.834%
5/14/2024	EntryPoint Capital LLC	4,420	$38K	0.0%	N/A	0.010%
5/1/2024	BNP Paribas Financial Markets	42,495	$0.36M	0.0%	-26.1%	0.096%
2/15/2024	PFM Health Sciences LP	3,262,500	$21.53M	1.3%	-22.3%	7.388%
2/14/2024	RTW Investments LP	2,298,662	$15.17M	0.2%	N/A	5.205%
2/7/2024	BNP Paribas Financial Markets	57,466	$0.38M	0.0%	+164.9%	0.130%
11/15/2023	Rock Springs Capital Management LP	677,005	$2.09M	0.1%	+2.1%	1.535%
11/9/2023	Group One Trading L.P.	41,860	$0.13M	0.0%	-14.2%	0.095%
11/9/2023	Rhenman & Partners Asset Management AB	234,000	$0.72M	0.1%	-34.4%	0.531%
8/14/2023	Rock Springs Capital Management LP	663,317	$1.79M	0.0%	+26.4%	1.504%
8/14/2023	Driehaus Capital Management LLC	28,300	$76K	0.0%	-89.3%	0.064%
8/11/2023	Cibc World Market Inc.	160,643	$0.43M	0.0%	-23.1%	0.364%
7/26/2023	Privium Fund Management B.V.	20,032	$55K	0.0%	N/A	0.045%
5/16/2023	Ally Bridge Group NY LLC	236,583	$0.70M	0.9%	-70.8%	0.537%
5/12/2023	Rhenman & Partners Asset Management AB	356,500	$1.05M	0.1%	-4.9%	0.809%
5/3/2023	Privium Fund Management UK Ltd	20,032	$61K	0.0%	N/A	0.045%
2/15/2023	Avidity Partners Management LP	1,855,400	$4.68M	0.1%	-24.6%	4.208%
2/14/2023	Driehaus Capital Management LLC	264,571	$0.67M	0.0%	N/A	0.600%
2/3/2023	Frazier Life Sciences Management L.P.	605,141	$1.53M	0.1%	-12.7%	1.373%
11/15/2022	PFM Health Sciences LP	1,478,252	$2.69M	0.1%	+53.7%	3.354%
11/15/2022	Eventide Asset Management LLC	1,561,251	$2.84M	0.1%	-53.6%	3.543%
11/15/2022	BVF Inc. IL	8,748,629	$15.92M	0.7%	+136.5%	19.852%
11/15/2022	Bellevue Group AG	5,898,583	$10.74M	0.2%	+17.7%	13.385%
11/15/2022	Bioimpact Capital LLC	405,700	$0.74M	0.2%	-38.6%	0.921%
11/14/2022	RTW Investments LP	1,311,294	$2.39M	0.1%	-50.3%	2.975%
11/10/2022	AlpInvest Partners B.V.	39,930	$73K	0.0%	-62.5%	0.091%
8/12/2022	Ensign Peak Advisors Inc	26,282	$83K	0.0%	-70.6%	0.060%
8/11/2022	Trexquant Investment LP	19,147	$60K	0.0%	+24.3%	0.043%
8/11/2022	Alps Advisors Inc.	26,140	$82K	0.0%	N/A	0.059%
8/10/2022	Cibc World Market Inc.	94,578	$0.30M	0.0%	-17.9%	0.215%
8/8/2022	Walleye Capital LLC	104,393	$0.33M	0.0%	+75.8%	0.237%
8/3/2022	Candriam S.C.A.	567,343	$1.79M	0.0%	-3.5%	1.289%
5/17/2022	Eventide Asset Management LLC	4,170,259	$25.77M	0.4%	+25.7%	9.474%
5/16/2022	Blackstone Inc.	2,003,103	$12.38M	0.0%	-39.4%	4.551%
5/16/2022	Frazier Life Sciences Management L.P.	692,910	$4.28M	0.4%	N/A	1.574%
5/9/2022	Qube Research & Technologies Ltd	47,655	$0.30M	0.0%	N/A	0.108%
5/4/2022	Prospera Financial Services Inc	7,568	$47K	0.0%	N/A	0.017%
5/2/2022	Cannon Global Investment Management LLC	15,300	$95K	0.1%	N/A	0.035%
4/27/2022	Alta Wealth Advisors LLC	11,285	$70K	0.0%	N/A	0.026%
3/10/2022	Values First Advisors Inc.	13,668	$0.19M	0.1%	N/A	0.031%
2/19/2022	Woodline Partners LP	684,247	$9.72M	0.1%	+286.6%	1.556%
2/15/2022	CIBC World Markets Inc.	84,230	$1.20M	0.0%	N/A	0.192%
2/14/2022	Virtus ETF Advisers LLC	13,643	$0.19M	0.1%	+74.3%	0.031%
2/14/2022	Altium Capital Management LP	345,000	$4.90M	1.4%	N/A	0.784%
2/14/2022	Boxer Capital LLC	724,500	$10.29M	0.4%	+5.5%	1.647%
2/14/2022	Soleus Capital Management L.P.	3,525,457	$50.06M	5.0%	+22.9%	8.015%
2/14/2022	Eventide Asset Management LLC	3,318,647	$47.13M	0.6%	+52.2%	7.545%
2/11/2022	Ensign Peak Advisors Inc	89,448	$1.27M	0.0%	+7.7%	0.203%
2/11/2022	Bioimpact Capital LLC	668,688	$9.50M	1.7%	-2.1%	1.520%
2/10/2022	Candriam Luxembourg S.C.A.	626,276	$8.89M	0.1%	+108.4%	1.424%
2/8/2022	Frazier Management LLC	543,470	$7.72M	0.6%	+51.7%	1.236%
2/8/2022	Swiss National Bank	53,200	$0.76M	0.0%	+8.4%	0.121%
2/3/2022	Advisor Group Holdings Inc.	4,559	$65K	0.0%	-28.8%	0.010%
12/17/2021	Jefferies Group LLC	62,502	$0.50M	0.0%	N/A	0.142%
11/16/2021	Schonfeld Strategic Advisors LLC	10,600	$85K	0.0%	-87.8%	0.024%
11/16/2021	Janus Henderson Group PLC	3,477,844	$27.84M	0.0%	+72.4%	7.907%
11/16/2021	Two Sigma Advisers LP	564,800	$4.52M	0.0%	+1,319.1%	1.284%
11/16/2021	Two Sigma Investments LP	502,406	$4.02M	0.0%	+1,658.9%	1.142%
11/16/2021	BVF Inc. IL	2,851,461	$22.81M	0.9%	+16.3%	6.483%
11/16/2021	BioImpact Capital LLC	683,287	$5.47M	0.8%	N/A	1.553%
11/16/2021	Citadel Advisors LLC	685,531	$5.49M	0.0%	-4.9%	1.559%
11/15/2021	RTW Investments LP	2,637,192	$21.10M	0.3%	-13.6%	5.996%
11/15/2021	Rock Springs Capital Management LP	508,044	$4.06M	0.1%	+1.0%	1.155%
11/15/2021	Sphera Funds Management LTD.	469,402	$3.76M	0.3%	-27.6%	1.067%
11/15/2021	HighVista Strategies LLC	143,566	$1.15M	0.8%	+497.5%	0.326%
11/15/2021	Ensign Peak Advisors Inc	83,068	$0.67M	0.0%	-53.4%	0.189%
11/12/2021	Renaissance Technologies LLC	141,500	$1.13M	0.0%	+618.3%	0.322%
11/12/2021	Macquarie Group Ltd.	6,106	$49K	0.0%	N/A	0.014%
11/12/2021	Credit Suisse AG	13,713	$0.11M	0.0%	+12.2%	0.031%
11/12/2021	Oppenheimer & Co. Inc.	47,300	$0.38M	0.0%	N/A	0.108%
11/12/2021	Bellevue Group AG	5,034,814	$40.28M	0.4%	+104.7%	11.447%
11/12/2021	Rhenman & Partners Asset Management AB	600,000	$4.80M	0.3%	+130.8%	1.364%
11/10/2021	Goldman Sachs Group Inc.	121,601	$0.97M	0.0%	+82.1%	0.276%

Data available starting January 2016

See Full Table

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Today's Range

Now: $1.63

$1.61

$1.67

50 Day Range

MA: $1.72

$1.61

$1.92

52 Week Range

Now: $1.63

$1.40

$9.60

Volume

89,483 shs

Average Volume

210,873 shs

Market Capitalization

$72.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Who are the company insiders with the largest holdings of ESSA Pharma?: ESSA Pharma's top insider investors include:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Peter Virsik (COO)
Growth N V Biotech (Major Shareholder)
Learn More about top insider investors at ESSA Pharma.
Who are the major institutional investors of ESSA Pharma?: ESSA Pharma's top institutional investors include:
Tang Capital Management LLC — 9.69%
BML Capital Management LLC — 9.51%
Soleus Capital Management L.P. — 5.10%
Altium Capital Management LLC — 3.22%
RTW Investments LP — 2.51%
Bank of America Corp DE — 1.83%
Learn More about top institutional investors of ESSA Pharma stock.
Which institutional investors are selling ESSA Pharma stock?: In the last quarter, EPIX stock was sold by these institutional investors:
RTW Investments LP
Soleus Capital Management L.P.
Schonfeld Strategic Advisors LLC
Citadel Advisors LLC
During the last year, company insiders that have sold ESSA Pharma company stock include:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Learn More investors selling ESSA Pharma stock.
Which institutional investors are buying ESSA Pharma stock?: In the last quarter, EPIX stock was bought by institutional investors including:
Tang Capital Management LLC
BML Capital Management LLC
Altium Capital Management LLC
Bank of America Corp DE
Aldebaran Capital LLC
Two Sigma Investments LP
Marshall Wace LLP
BNP Paribas Financial Markets
In the last year, these company insiders have bought ESSA Pharma stock:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Learn More investors buying ESSA Pharma stock.